Pfizer Reaps Big Profits on Vaccine

New York Times: “Last year, racing to develop a vaccine in record time, Pfizer made a big decision: Unlike several rival manufacturers, which vowed to forgo profits on their shots during the Covid-19 pandemic, Pfizer planned to profit on its vaccine.”

“On Tuesday, the company announced the vaccine brought in $3.5 billion in revenue in the first three months of this year, nearly a quarter of its total revenue.”